Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effects of Spironolactone and Propranolol in Alcoholic Cirrhosis
NCT00188045Phase 4Terminated
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Apr 1995
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of spironolactone, propranolol in alcoholic cirrhosis, sponsored by Centre Hospitalier Universitaire d'Angers. Started Apr 1995; status: terminated.
02
Drugs
spironolactonepropranolol
03
Conditions
alcoholic cirrhosis
Beyond the preview
Go deeper on NCT00188045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00188045.